Discover Tenders by Non Decaffeinated Coffee Sector

Find the most relevant tenders for Non Decaffeinated Coffee. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Decaffeinated Coffee tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Decaffeinated Coffee tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Foreign Aneusumab Atc N02Cd03 For The Period 01 07 2025 30 06 2027

Deadline: 05 May 2027

Germany

Ref. No.: 16543890

EMD:Ref Document

Bid Value: Ref Document

615 Days Left

Completion Of Non Exclusive Discount Agreements According To 130 A 8 Sgb V With The Active Ingredient Epoetin Zeta

Deadline: 10 May 2027

Germany

Ref. No.: 16543263

EMD:Ref Document

Bid Value: Ref Document

620 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Lamivudin Abacavir Dolutegravir Atc J05Ar13 For The Time 01 07 2025 30 06 2027

Deadline: 05 May 2027

Germany

Ref. No.: 16542066

EMD:Ref Document

Bid Value: Ref Document

615 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Denosumab Atc M05Bx04 For The Time 01 07 2025 30 06 2026 Plus Extension Option 1X 12 Months

Deadline: 05 May 2027

Germany

Ref. No.: 16541317

EMD:Ref Document

Bid Value: Ref Document

615 Days Left

Completion Of A Non Exclusive Discount Agreement According To 130A Paragraph 8 Sgb V On The Active Ingredient Vedolizumab Atc L04Aa33 For The Period 01 07 2025 30 06 2027

Deadline: 05 May 2027

Germany

Ref. No.: 16540758

EMD:Ref Document

Bid Value: Ref Document

615 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Dolutegravir Rilpivirin Atc J05Ar21 For The Time 01 07 2025 30 06 2027

Deadline: 05 May 2027

Germany

Ref. No.: 16540538

EMD:Ref Document

Bid Value: Ref Document

615 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V For The Active Ingredient Golumumab Atc L04Ab06 For The Time 01 07 2025 30 06 2027

Deadline: 05 May 2027

Germany

Ref. No.: 16539329

EMD:Ref Document

Bid Value: Ref Document

615 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V To The Active Ingredient Sapropter Exclusively Dosage Form Ple Atc A16Ax07 For The Time 01 07 2025 30 06 2027

Deadline: 05 May 2027

Germany

Ref. No.: 16538132

EMD:Ref Document

Bid Value: Ref Document

615 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Lapatinib Atc L01Eh01 For The Time 01 07 2025 30 06 2027 Plus Extension Option 1X 12 Months

Deadline: 05 May 2028

Germany

Ref. No.: 16538007

EMD:Ref Document

Bid Value: Ref Document

981 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Lamivudin Dolutegravir Atc J05Ar25 For The Period 01 07 2025 30 06 2027

Deadline: 05 May 2027

Germany

Ref. No.: 16535946

EMD:Ref Document

Bid Value: Ref Document

615 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Epinephrin Atc C01Ca24 For The Time 01 07 2025 30 06 2027 Plus Extension Option 1X12 Months

Deadline: 05 May 2028

Germany

Ref. No.: 16535668

EMD:Ref Document

Bid Value: Ref Document

981 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Lamivudin Abacavir Dolutegravir Atc J05Ar13 For The Time 01 07 2025 30 06 2027

Deadline: 05 May 2027

Germany

Ref. No.: 16534843

EMD:Ref Document

Bid Value: Ref Document

615 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V To The Active Ingredient Glatirameracetate Exclusively Dosage Form Atc L03Ax13 For The Time 01 07 25 30 06 27

Deadline: 05 May 2027

Germany

Ref. No.: 16534804

EMD:Ref Document

Bid Value: Ref Document

615 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Cyanocobalamin Atc B03Ba01 For The Period 01 07 2025 30 06 2027 Plus Extension Option 1X 12 Months

Deadline: 05 May 2028

Germany

Ref. No.: 16534778

EMD:Ref Document

Bid Value: Ref Document

981 Days Left

Completion Of A Non Exclusive Discount Agreement According To Section 130A 8 Sgb V On The Active Ingredient Lanreotide Atc H01Cb03 For The Time 01 07 2025 30 06 2026 Plus Extension Option 1X 12 Months

Deadline: 05 May 2027

Germany

Ref. No.: 16534774

EMD:Ref Document

Bid Value: Ref Document

615 Days Left

Showing 24766 to 24780 of 26648 results

‹
1
2
...
1649
1650
1651
1652
1653
1654
1655
...
1776
1777
›

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

FREE Trial plan for all new users!